Tasigna MDL Created For 20 Cases, But JPMDL Says More Case Are Likely

Mealey's (August 12, 2021, 1:14 PM EDT) -- WASHINGTON, D.C. — The Judicial Panel on Multidistrict Litigation (JPMDL) on Aug. 10 centralized 20 federal lawsuits alleging that the chemotherapy drug Tasigna caused atherosclerotic injuries, citing the centralization of 186...
To view the full article, register now.